Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
Recruiting · NCT06959511 · Registry updated 2026-09-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery | Head and Neck Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, neoplasm, thyroid gland disorder, thyroid tumor | Recruiting | Phase 2 | 2026-09-04 | NCT06959511 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Exelixis | 77 |
| M.D. Anderson Cancer Center | 1145 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cleveland Clinic Taussig Cancer Institute | Cleveland | United States | 8 |
| MD Anderson Cancer Center | Houston | United States | 589 |
| University of Michigan | Ann Arbor | United States | 538 |
| University of Virginia | Charlottesville | United States | 122 |